1 year return (CAGR)
-50.43%
Myriad Genetics Inc Exchange (NASDAQ, USD)
MYGN
3.42
+0.06 (+1.79%)
HealthcareDiagnostics & Research
Loading...
3 year return (CAGR)
-41.59%
5 year return (CAGR)
-37.57%
10 year return (CAGR)
-16.34%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
327.12M
Price/Sales
0.41
Ent value
546.92M
Price/Book
1.08
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
62.26%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.37 |
| Daily high | 3.42 |
| Daily low | 3.19 |
| Daily Volume | 2.55M |
| All-time high | 61.27 |
| 1y analyst estimate | 3.34 |
| Beta | 1.64 |
| EPS (TTM) | -1.19 |
| Dividend per share | 0.00 |
| Ex-div date | 1 Jul 2009 |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| MYGN | S&P500 | |
| Current price drop from All-time high | -94.42% | -1.75% |
| Highest price drop | -95.33% | -56.47% |
| Date of highest drop | 31 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -61.49% | -10.68% |
| Avg time to new high | 150 days | 12 days |
| Max time to new high | 6499 days | 1805 days |
News
